▶ 調査レポート

世界のCRISPRゲノム編集市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global CRISPR Genome Editing Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のCRISPRゲノム編集市場規模・現状・予測(2021年-2027年) / Global CRISPR Genome Editing Market Size, Status and Forecast 2021-2027 / QFJ1-4066資料のイメージです。• レポートコード:QFJ1-4066
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、124ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、CRISPRゲノム編集の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(遺伝子工学、遺伝子ライブラリー、ヒト幹細胞、その他)、用途別市場規模(バイオテクノロジー企業、製薬企業、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・CRISPRゲノム編集の市場動向
・企業の競争状況、市場シェア
・CRISPRゲノム編集の種類別市場規模と予測2016-2027(遺伝子工学、遺伝子ライブラリー、ヒト幹細胞、その他)
・CRISPRゲノム編集の用途別市場規模と予測2016-2027(バイオテクノロジー企業、製薬企業、その他)
・CRISPRゲノム編集の北米市場規模2016-2027(アメリカ、カナダ)
・CRISPRゲノム編集の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・CRISPRゲノム編集のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・CRISPRゲノム編集の中南米市場規模2016-2027(メキシコ、ブラジル)
・CRISPRゲノム編集の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Editas Medicine、CRISPR Therapeutics、Horizon Discovery、Sigma-Aldrich、Genscript、Sangamo Biosciences、Lonza Group、Integrated DNA Technologies、New England Biolabs、Origene Technologies、Transposagen Biopharmaceuticals、Thermo Fisher Scientific、Caribou Biosciences、Precision Biosciences、Cellectis、Intellia Therapeutics)
・結論

CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR.

Market Analysis and Insights: Global CRISPR Genome Editing Market
The global CRISPR Genome Editing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRISPR Genome Editing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRISPR Genome Editing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRISPR Genome Editing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRISPR Genome Editing market.

Global CRISPR Genome Editing Scope and Market Size
CRISPR Genome Editing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR Genome Editing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Genetic Engineering
Gene Library
Human Stem Cells
Others

Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Editas Medicine
CRISPR Therapeutics
Horizon Discovery
Sigma-Aldrich
Genscript
Sangamo Biosciences
Lonza Group
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Thermo Fisher Scientific
Caribou Biosciences
Precision Biosciences
Cellectis
Intellia Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR Genome Editing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Genetic Engineering
1.2.3 Gene Library
1.2.4 Human Stem Cells
1.2.5 Others
1.3 Market by Application
1.3.1 Global CRISPR Genome Editing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CRISPR Genome Editing Market Perspective (2016-2027)
2.2 CRISPR Genome Editing Growth Trends by Regions
2.2.1 CRISPR Genome Editing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CRISPR Genome Editing Historic Market Share by Regions (2016-2021)
2.2.3 CRISPR Genome Editing Forecasted Market Size by Regions (2022-2027)
2.3 CRISPR Genome Editing Industry Dynamic
2.3.1 CRISPR Genome Editing Market Trends
2.3.2 CRISPR Genome Editing Market Drivers
2.3.3 CRISPR Genome Editing Market Challenges
2.3.4 CRISPR Genome Editing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CRISPR Genome Editing Players by Revenue
3.1.1 Global Top CRISPR Genome Editing Players by Revenue (2016-2021)
3.1.2 Global CRISPR Genome Editing Revenue Market Share by Players (2016-2021)
3.2 Global CRISPR Genome Editing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRISPR Genome Editing Revenue
3.4 Global CRISPR Genome Editing Market Concentration Ratio
3.4.1 Global CRISPR Genome Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Genome Editing Revenue in 2020
3.5 CRISPR Genome Editing Key Players Head office and Area Served
3.6 Key Players CRISPR Genome Editing Product Solution and Service
3.7 Date of Enter into CRISPR Genome Editing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR Genome Editing Breakdown Data by Type
4.1 Global CRISPR Genome Editing Historic Market Size by Type (2016-2021)
4.2 Global CRISPR Genome Editing Forecasted Market Size by Type (2022-2027)

5 CRISPR Genome Editing Breakdown Data by Application
5.1 Global CRISPR Genome Editing Historic Market Size by Application (2016-2021)
5.2 Global CRISPR Genome Editing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CRISPR Genome Editing Market Size (2016-2027)
6.2 North America CRISPR Genome Editing Market Size by Type
6.2.1 North America CRISPR Genome Editing Market Size by Type (2016-2021)
6.2.2 North America CRISPR Genome Editing Market Size by Type (2022-2027)
6.2.3 North America CRISPR Genome Editing Market Size by Type (2016-2027)
6.3 North America CRISPR Genome Editing Market Size by Application
6.3.1 North America CRISPR Genome Editing Market Size by Application (2016-2021)
6.3.2 North America CRISPR Genome Editing Market Size by Application (2022-2027)
6.3.3 North America CRISPR Genome Editing Market Size by Application (2016-2027)
6.4 North America CRISPR Genome Editing Market Size by Country
6.4.1 North America CRISPR Genome Editing Market Size by Country (2016-2021)
6.4.2 North America CRISPR Genome Editing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe CRISPR Genome Editing Market Size (2016-2027)
7.2 Europe CRISPR Genome Editing Market Size by Type
7.2.1 Europe CRISPR Genome Editing Market Size by Type (2016-2021)
7.2.2 Europe CRISPR Genome Editing Market Size by Type (2022-2027)
7.2.3 Europe CRISPR Genome Editing Market Size by Type (2016-2027)
7.3 Europe CRISPR Genome Editing Market Size by Application
7.3.1 Europe CRISPR Genome Editing Market Size by Application (2016-2021)
7.3.2 Europe CRISPR Genome Editing Market Size by Application (2022-2027)
7.3.3 Europe CRISPR Genome Editing Market Size by Application (2016-2027)
7.4 Europe CRISPR Genome Editing Market Size by Country
7.4.1 Europe CRISPR Genome Editing Market Size by Country (2016-2021)
7.4.2 Europe CRISPR Genome Editing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CRISPR Genome Editing Market Size (2016-2027)
8.2 Asia-Pacific CRISPR Genome Editing Market Size by Type
8.2.1 Asia-Pacific CRISPR Genome Editing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CRISPR Genome Editing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CRISPR Genome Editing Market Size by Type (2016-2027)
8.3 Asia-Pacific CRISPR Genome Editing Market Size by Application
8.3.1 Asia-Pacific CRISPR Genome Editing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CRISPR Genome Editing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CRISPR Genome Editing Market Size by Application (2016-2027)
8.4 Asia-Pacific CRISPR Genome Editing Market Size by Region
8.4.1 Asia-Pacific CRISPR Genome Editing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CRISPR Genome Editing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CRISPR Genome Editing Market Size (2016-2027)
9.2 Latin America CRISPR Genome Editing Market Size by Type
9.2.1 Latin America CRISPR Genome Editing Market Size by Type (2016-2021)
9.2.2 Latin America CRISPR Genome Editing Market Size by Type (2022-2027)
9.2.3 Latin America CRISPR Genome Editing Market Size by Type (2016-2027)
9.3 Latin America CRISPR Genome Editing Market Size by Application
9.3.1 Latin America CRISPR Genome Editing Market Size by Application (2016-2021)
9.3.2 Latin America CRISPR Genome Editing Market Size by Application (2022-2027)
9.3.3 Latin America CRISPR Genome Editing Market Size by Application (2016-2027)
9.4 Latin America CRISPR Genome Editing Market Size by Country
9.4.1 Latin America CRISPR Genome Editing Market Size by Country (2016-2021)
9.4.2 Latin America CRISPR Genome Editing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CRISPR Genome Editing Market Size (2016-2027)
10.2 Middle East & Africa CRISPR Genome Editing Market Size by Type
10.2.1 Middle East & Africa CRISPR Genome Editing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CRISPR Genome Editing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CRISPR Genome Editing Market Size by Type (2016-2027)
10.3 Middle East & Africa CRISPR Genome Editing Market Size by Application
10.3.1 Middle East & Africa CRISPR Genome Editing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CRISPR Genome Editing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CRISPR Genome Editing Market Size by Application (2016-2027)
10.4 Middle East & Africa CRISPR Genome Editing Market Size by Country
10.4.1 Middle East & Africa CRISPR Genome Editing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CRISPR Genome Editing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Editas Medicine
11.1.1 Editas Medicine Company Details
11.1.2 Editas Medicine Business Overview
11.1.3 Editas Medicine CRISPR Genome Editing Introduction
11.1.4 Editas Medicine Revenue in CRISPR Genome Editing Business (2016-2021)
11.1.5 Editas Medicine Recent Development
11.2 CRISPR Therapeutics
11.2.1 CRISPR Therapeutics Company Details
11.2.2 CRISPR Therapeutics Business Overview
11.2.3 CRISPR Therapeutics CRISPR Genome Editing Introduction
11.2.4 CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2016-2021)
11.2.5 CRISPR Therapeutics Recent Development
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Details
11.3.2 Horizon Discovery Business Overview
11.3.3 Horizon Discovery CRISPR Genome Editing Introduction
11.3.4 Horizon Discovery Revenue in CRISPR Genome Editing Business (2016-2021)
11.3.5 Horizon Discovery Recent Development
11.4 Sigma-Aldrich
11.4.1 Sigma-Aldrich Company Details
11.4.2 Sigma-Aldrich Business Overview
11.4.3 Sigma-Aldrich CRISPR Genome Editing Introduction
11.4.4 Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2016-2021)
11.4.5 Sigma-Aldrich Recent Development
11.5 Genscript
11.5.1 Genscript Company Details
11.5.2 Genscript Business Overview
11.5.3 Genscript CRISPR Genome Editing Introduction
11.5.4 Genscript Revenue in CRISPR Genome Editing Business (2016-2021)
11.5.5 Genscript Recent Development
11.6 Sangamo Biosciences
11.6.1 Sangamo Biosciences Company Details
11.6.2 Sangamo Biosciences Business Overview
11.6.3 Sangamo Biosciences CRISPR Genome Editing Introduction
11.6.4 Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2016-2021)
11.6.5 Sangamo Biosciences Recent Development
11.7 Lonza Group
11.7.1 Lonza Group Company Details
11.7.2 Lonza Group Business Overview
11.7.3 Lonza Group CRISPR Genome Editing Introduction
11.7.4 Lonza Group Revenue in CRISPR Genome Editing Business (2016-2021)
11.7.5 Lonza Group Recent Development
11.8 Integrated DNA Technologies
11.8.1 Integrated DNA Technologies Company Details
11.8.2 Integrated DNA Technologies Business Overview
11.8.3 Integrated DNA Technologies CRISPR Genome Editing Introduction
11.8.4 Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2016-2021)
11.8.5 Integrated DNA Technologies Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs CRISPR Genome Editing Introduction
11.9.4 New England Biolabs Revenue in CRISPR Genome Editing Business (2016-2021)
11.9.5 New England Biolabs Recent Development
11.10 Origene Technologies
11.10.1 Origene Technologies Company Details
11.10.2 Origene Technologies Business Overview
11.10.3 Origene Technologies CRISPR Genome Editing Introduction
11.10.4 Origene Technologies Revenue in CRISPR Genome Editing Business (2016-2021)
11.10.5 Origene Technologies Recent Development
11.11 Transposagen Biopharmaceuticals
11.11.1 Transposagen Biopharmaceuticals Company Details
11.11.2 Transposagen Biopharmaceuticals Business Overview
11.11.3 Transposagen Biopharmaceuticals CRISPR Genome Editing Introduction
11.11.4 Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2016-2021)
11.11.5 Transposagen Biopharmaceuticals Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific CRISPR Genome Editing Introduction
11.12.4 Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2016-2021)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Caribou Biosciences
11.13.1 Caribou Biosciences Company Details
11.13.2 Caribou Biosciences Business Overview
11.13.3 Caribou Biosciences CRISPR Genome Editing Introduction
11.13.4 Caribou Biosciences Revenue in CRISPR Genome Editing Business (2016-2021)
11.13.5 Caribou Biosciences Recent Development
11.14 Precision Biosciences
11.14.1 Precision Biosciences Company Details
11.14.2 Precision Biosciences Business Overview
11.14.3 Precision Biosciences CRISPR Genome Editing Introduction
11.14.4 Precision Biosciences Revenue in CRISPR Genome Editing Business (2016-2021)
11.14.5 Precision Biosciences Recent Development
11.15 Cellectis
11.15.1 Cellectis Company Details
11.15.2 Cellectis Business Overview
11.15.3 Cellectis CRISPR Genome Editing Introduction
11.15.4 Cellectis Revenue in CRISPR Genome Editing Business (2016-2021)
11.15.5 Cellectis Recent Development
11.16 Intellia Therapeutics
11.16.1 Intellia Therapeutics Company Details
11.16.2 Intellia Therapeutics Business Overview
11.16.3 Intellia Therapeutics CRISPR Genome Editing Introduction
11.16.4 Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2016-2021)
11.16.5 Intellia Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global CRISPR Genome Editing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Genetic Engineering
Table 3. Key Players of Gene Library
Table 4. Key Players of Human Stem Cells
Table 5. Key Players of Others
Table 6. Global CRISPR Genome Editing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global CRISPR Genome Editing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global CRISPR Genome Editing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global CRISPR Genome Editing Market Share by Regions (2016-2021)
Table 10. Global CRISPR Genome Editing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global CRISPR Genome Editing Market Share by Regions (2022-2027)
Table 12. CRISPR Genome Editing Market Trends
Table 13. CRISPR Genome Editing Market Drivers
Table 14. CRISPR Genome Editing Market Challenges
Table 15. CRISPR Genome Editing Market Restraints
Table 16. Global CRISPR Genome Editing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global CRISPR Genome Editing Market Share by Players (2016-2021)
Table 18. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR Genome Editing as of 2020)
Table 19. Ranking of Global Top CRISPR Genome Editing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by CRISPR Genome Editing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players CRISPR Genome Editing Product Solution and Service
Table 23. Date of Enter into CRISPR Genome Editing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global CRISPR Genome Editing Revenue Market Share by Type (2016-2021)
Table 27. Global CRISPR Genome Editing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global CRISPR Genome Editing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global CRISPR Genome Editing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global CRISPR Genome Editing Revenue Market Share by Application (2016-2021)
Table 31. Global CRISPR Genome Editing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global CRISPR Genome Editing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America CRISPR Genome Editing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America CRISPR Genome Editing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America CRISPR Genome Editing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America CRISPR Genome Editing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America CRISPR Genome Editing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe CRISPR Genome Editing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe CRISPR Genome Editing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe CRISPR Genome Editing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe CRISPR Genome Editing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe CRISPR Genome Editing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific CRISPR Genome Editing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific CRISPR Genome Editing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific CRISPR Genome Editing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific CRISPR Genome Editing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific CRISPR Genome Editing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America CRISPR Genome Editing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America CRISPR Genome Editing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America CRISPR Genome Editing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America CRISPR Genome Editing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America CRISPR Genome Editing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa CRISPR Genome Editing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa CRISPR Genome Editing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa CRISPR Genome Editing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa CRISPR Genome Editing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa CRISPR Genome Editing Market Size by Country (2022-2027) & (US$ Million)
Table 63. Editas Medicine Company Details
Table 64. Editas Medicine Business Overview
Table 65. Editas Medicine CRISPR Genome Editing Product
Table 66. Editas Medicine Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 67. Editas Medicine Recent Development
Table 68. CRISPR Therapeutics Company Details
Table 69. CRISPR Therapeutics Business Overview
Table 70. CRISPR Therapeutics CRISPR Genome Editing Product
Table 71. CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 72. CRISPR Therapeutics Recent Development
Table 73. Horizon Discovery Company Details
Table 74. Horizon Discovery Business Overview
Table 75. Horizon Discovery CRISPR Genome Editing Product
Table 76. Horizon Discovery Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 77. Horizon Discovery Recent Development
Table 78. Sigma-Aldrich Company Details
Table 79. Sigma-Aldrich Business Overview
Table 80. Sigma-Aldrich CRISPR Genome Editing Product
Table 81. Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 82. Sigma-Aldrich Recent Development
Table 83. Genscript Company Details
Table 84. Genscript Business Overview
Table 85. Genscript CRISPR Genome Editing Product
Table 86. Genscript Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 87. Genscript Recent Development
Table 88. Sangamo Biosciences Company Details
Table 89. Sangamo Biosciences Business Overview
Table 90. Sangamo Biosciences CRISPR Genome Editing Product
Table 91. Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 92. Sangamo Biosciences Recent Development
Table 93. Lonza Group Company Details
Table 94. Lonza Group Business Overview
Table 95. Lonza Group CRISPR Genome Editing Product
Table 96. Lonza Group Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 97. Lonza Group Recent Development
Table 98. Integrated DNA Technologies Company Details
Table 99. Integrated DNA Technologies Business Overview
Table 100. Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 101. Integrated DNA Technologies Recent Development
Table 102. New England Biolabs Company Details
Table 103. New England Biolabs Business Overview
Table 104. New England Biolabs CRISPR Genome Editing Product
Table 105. New England Biolabs Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 106. New England Biolabs Recent Development
Table 107. Origene Technologies Company Details
Table 108. Origene Technologies Business Overview
Table 109. Origene Technologies CRISPR Genome Editing Product
Table 110. Origene Technologies Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 111. Origene Technologies Recent Development
Table 112. Transposagen Biopharmaceuticals Company Details
Table 113. Transposagen Biopharmaceuticals Business Overview
Table 114. Transposagen Biopharmaceuticals CRISPR Genome Editing Product
Table 115. Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 116. Transposagen Biopharmaceuticals Recent Development
Table 117. Thermo Fisher Scientific Company Details
Table 118. Thermo Fisher Scientific Business Overview
Table 119. Thermo Fisher Scientific CRISPR Genome Editing Product
Table 120. Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 121. Thermo Fisher Scientific Recent Development
Table 122. Caribou Biosciences Company Details
Table 123. Caribou Biosciences Business Overview
Table 124. Caribou Biosciences CRISPR Genome Editing Product
Table 125. Caribou Biosciences Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 126. Caribou Biosciences Recent Development
Table 127. Precision Biosciences Company Details
Table 128. Precision Biosciences Business Overview
Table 129. Precision Biosciences CRISPR Genome Editing Product
Table 130. Precision Biosciences Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 131. Precision Biosciences Recent Development
Table 132. Cellectis Company Details
Table 133. Cellectis Business Overview
Table 134. Cellectis CRISPR Genome Editing Product
Table 135. Cellectis Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 136. Cellectis Recent Development
Table 137. Intellia Therapeutics Company Details
Table 138. Intellia Therapeutics Business Overview
Table 139. Intellia Therapeutics CRISPR Genome Editing Product
Table 140. Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
Table 141. Intellia Therapeutics Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR Genome Editing Market Share by Type: 2020 VS 2027
Figure 2. Genetic Engineering Features
Figure 3. Gene Library Features
Figure 4. Human Stem Cells Features
Figure 5. Others Features
Figure 6. Global CRISPR Genome Editing Market Share by Application: 2020 VS 2027
Figure 7. Biotechnology Companies Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Others Case Studies
Figure 10. CRISPR Genome Editing Report Years Considered
Figure 11. Global CRISPR Genome Editing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global CRISPR Genome Editing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global CRISPR Genome Editing Market Share by Regions: 2020 VS 2027
Figure 14. Global CRISPR Genome Editing Market Share by Regions (2022-2027)
Figure 15. Global CRISPR Genome Editing Market Share by Players in 2020
Figure 16. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR Genome Editing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by CRISPR Genome Editing Revenue in 2020
Figure 18. Global CRISPR Genome Editing Revenue Market Share by Type (2016-2021)
Figure 19. Global CRISPR Genome Editing Revenue Market Share by Type (2022-2027)
Figure 20. North America CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America CRISPR Genome Editing Market Share by Type (2016-2027)
Figure 22. North America CRISPR Genome Editing Market Share by Application (2016-2027)
Figure 23. North America CRISPR Genome Editing Market Share by Country (2016-2027)
Figure 24. United States CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe CRISPR Genome Editing Market Share by Type (2016-2027)
Figure 28. Europe CRISPR Genome Editing Market Share by Application (2016-2027)
Figure 29. Europe CRISPR Genome Editing Market Share by Country (2016-2027)
Figure 30. Germany CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific CRISPR Genome Editing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific CRISPR Genome Editing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific CRISPR Genome Editing Market Share by Region (2016-2027)
Figure 40. China CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America CRISPR Genome Editing Market Share by Type (2016-2027)
Figure 48. Latin America CRISPR Genome Editing Market Share by Application (2016-2027)
Figure 49. Latin America CRISPR Genome Editing Market Share by Country (2016-2027)
Figure 50. Mexico CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa CRISPR Genome Editing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa CRISPR Genome Editing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa CRISPR Genome Editing Market Share by Country (2016-2027)
Figure 56. Turkey CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Editas Medicine Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 60. CRISPR Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 61. Horizon Discovery Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 62. Sigma-Aldrich Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 63. Genscript Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 64. Sangamo Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 65. Lonza Group Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 66. Integrated DNA Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 67. New England Biolabs Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 68. Origene Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 69. Transposagen Biopharmaceuticals Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 70. Thermo Fisher Scientific Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 71. Caribou Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 72. Precision Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 73. Cellectis Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 74. Intellia Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed